The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc− cystine transporter: a new action for an old drug
Abstract
Although cyst(e)ine is nutritionally a non-essential amino acid, lymphoid cells cannot synthesize it, rendering their growth dependent on uptake of cyst(e)ine from their microenvironment. Accordingly, we previously suggested that the x(c)- plasma membrane cystine transporter provided a target for lymphoid cancer therapy. Its inhibition could lead to cyst(e)ine deficiency in lymphoma cells via reduction of both their cystine uptake and cysteine supply by somatic cells. In this study, using rat Nb2 lymphoma cultures, drugs were screened for growth arrest based on x(c)- inhibition. Sulfasalazine was fortuitously found to be a novel, potent inhibitor of the x(c)- transporter. It showed high rat lymphoma growth-inhibitory and lytic activity in vitro (IC50 = 0.16 mM), based specifically on inhibition of x(c)--mediated cystine uptake, in contrast to its colonic metabolites, sulfapyridine and 5-aminosalicylic acid. Sulfasalazine was even more effective against human non-Hodgkin's lymphoma (DoHH2) cultures. In rats (n = 13), sulfasalazine (i.p.) markedly inhibited growth of well-developed, rapidly growing rat Nb2 lymphoma transplants without apparent side-effects. Reduced, macrophage-mediated supply of cysteine was probably involved. In five rats, 90-100% tumor growth suppression, relative to controls, was obtained. The x(c)- cystine transporter represents a novel target for sulfasalazine-like drugs with high potential for application in therapy of lymphoblastic and other malignancies dependent on extracellular cyst(e)ine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DLBCLs with low system xc− activity are more susceptible to ferroptosis”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [77]
In the citing paper
“sulfasalazine potently inhibited the growth of lymphomas with low-level expression of SLC7A11, a subunit of system xc− [77, 78].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [77]
In the citing paper
“Since some leukemias and lymphomas have a defective transsulfuration pathway [76, 77]”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [77]
Citations
Cites
Goodman and Gilman's The Pharmacological Basis of Therapeutics
Hastings, R. C. (1996) · JAMA · doi:10.1001/jama.1996.03540120077042 · Cited by 2,375
Determination of subcutaneous tumor size in athymic (nude) mice
Tomayko, M. M., & Reynolds, C. P. (1989) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00300234 · Cited by 1,830
Cancer: Principles and Practice of Oncology
Gunn, W. G. (1994) · JAMA · doi:10.1001/jama.1994.03510350091047 · Cited by 1,803
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E. B., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,744
Sato, H., Tamba, M., Ishii, T., & Bannai, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11455 · Cited by 1,111
Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B
Wahl, C., Liptay, S., Adler, G., & Schmid, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci992 · Cited by 742
Wang, C.-Y., Guttridge, D. C., Mayo, M. W., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5923 · Cited by 594
Back, S. A., Gan, X., Li, Y., Rosenberg, P. A., & Volpe, J. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06241.1998 · Cited by 586
Exchange of cystine and glutamate across plasma membrane of human fibroblasts.
Bannai, S. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35926-4 · Cited by 549
Analgesic-Antipyretic and Antiinflammatory Agents and Drugs Employed in the Treatment of Gout
Insel, P. (1996) · Medical Entomology and Zoology · Cited by 416
Cited by
Sorted by citations
Items 401–500 of 644
The redox status of cystinotic fibroblasts
Vitvitsky, V., Witcher, M., Banerjee, R. V., & Thoene, J. G. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.12.010 · Cited by 16
The dynamic role of ferroptosis in cancer immunoediting: Implications for immunotherapy
Lan, J., Cai, D., Gou, S., Bai, Y., Lei, H., Li, Y., Chen, Y., Zhao, Y., Shen, J., Wu, S., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107674 · Cited by 16
Domka, K., Góral, A., & Firczuk, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01538 · Cited by 15
Tang, X., Niu, Y., Jian, J., Guo, Y., Wang, Y., Zhu, Y. F., & Liu, B. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104203 · Cited by 15
Mechanisms of ferroptosis and targeted therapeutic approaches in lymphoma
Yu, T., Xu-Monette, Z. Y., Li, Y., Li, Y., & Young, K. H. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06295-w · Cited by 21
Wang, C., Zhao, Y., Peng, Y., Chen, W., Zhu, J., Gu, C., Huo, R., Ding, L., Liu, T., Liu, T., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156417 · Cited by 15
Novel Insights in the Regulatory Mechanisms of Ferroptosis in Hepatocellular Carcinoma
Ma, S., Adzavon, Y. M., Wen, X., Zhao, P., Xie, F., Liu, M., & Ma, X. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.873029 · Cited by 15
Chintala, S., Tóth, K., Yin, M.-B., Bhattacharya, A., Smith, S. B., Ola, M. S., Cao, S., Durrani, F. A., Zinia, T. R., Dean, R., et al. (2010) · Chemotherapy · doi:10.1159/000316334 · Cited by 15
Wang, J., Hao, S., Song, G., Wang, Y., & Hao, Q. (2023) · PeerJ · doi:10.7717/peerj.14931 · Cited by 14
Role of ferroptosis in esophageal cancer and corresponding immunotherapy
Fan, X., Fan, Y.-T., Zeng, H., Dong, X.-Q., Lu, M., & Zhang, Z. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i7.1105 · Cited by 14
Li, N., Wang, R., Ai, X., Guo, J., Bai, Y., Guo, X., Zhang, R., Du, X., Chen, J., & Li, H. (2024) · Current Neurovascular Research · doi:10.2174/0115672026297775240405073502 · Cited by 14
Zhou, J., Han, J., Wei, Y., & Wang, Y. (2024) · The FASEB Journal · doi:10.1096/fj.202400638r · Cited by 14
Programmed cell death and melatonin: A comprehensive review
Rafiyan, M., Reiter, R. J., Manesh, S. M. R., Asemi, R., Sharifi, M., Mohammadi, S., Mansournia, M. A., & Asemi, Z. (2024) · Functional & Integrative Genomics · doi:10.1007/s10142-024-01454-4 · Cited by 14
Oxidative stress and cancer pain
Ungard, R. G., Seidlitz, E. P., & Singh, G. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0298 · Cited by 16
Metabolic Gatekeepers of Pathological B Cell Activation
Sadras, T., Chan, L. N., Xiao, G., & Müschen, M. (2020) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-061020-050135 · Cited by 17
Li, L., Li, H., Li, Y., Feng, J., Guan, D., Zhang, Y., Fu, Y., Li, S., & Li, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5594059 · Cited by 14
Szulc, A., & Woźniak, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209902 · Cited by 17
Selenium nanoparticles decorated by fucoidan induce ferroptosis in HepG2 cells
Chen, Y., Liu, X., Chen, B., Zhu, F., Wang, Z., Cheong, K., Ye, S., Zhong, S., & Chen, J. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.138841 · Cited by 13
Engineering Modular Peptide Nanoparticles for Ferroptosis‐Enhanced Tumor Immunotherapy
Wu, B., Yang, X., Kong, N., Liang, J., Li, S., & Wang, H. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202421703 · Cited by 13
Khodade, V. S., Liu, Q., Zhang, C., Keceli, G., Paolocci, N., & Toscano, J. P. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c17661 · Cited by 13
Identifying Prognostic Features by Bottom-Up Approach and Correlating to Drug Repositioning
Li, W., Yu, J., Lian, B., Sun, H., Li, J., Zhang, M., Li, L., Li, Y., Liu, Q., & Xie, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118672 · Cited by 13
Chemical hybridization of sulfasalazine and dihydroartemisinin promotes brain tumor cell death
Ackermann, A., Çapcı, A., Buchfelder, M., Tsogoeva, S. B., & Savaskan, N. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-99960-z · Cited by 13
Qin, X., Zhang, S., Guo, X., Liu, X., & Shen, X. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1062781 · Cited by 12
Tsai, W., Tsai, R., Liu, C., Wu, J., & Wong, C. (2015) · Journal of Orthopaedic Research® · doi:10.1002/jor.23069 · Cited by 13
Reactive oxygen species and cancer
Kong, H., & Chandel, N. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-818606-0.00030-4 · Cited by 12
Chronic Sulfasalazine Treatment in Mice Induces System xc− - Independent Adverse Effects
Verbruggen, L., Sprimont, L., Bentea, E., Janssen, P., Gharib, A., Deneyer, L., Pauw, L. D., Lara, O., Sato, H., Nicaise, C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.625699 · Cited by 12
Priyanka, Gupta, S., Vatsa, M., & Mondal, S. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104546 · Cited by 13
Xue, W., Yu, Y., Yao, Y., Zhou, L., Huang, Y., Wang, Y., Chen, Z., Wang, L., Li, X., Wang, X., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103034 · Cited by 11
Ali, A., Babar, Q., Saeed, A., Sergi, D., Naumovski, N., Ahmed, I. A. M., Shamlan, G. H., Hafiz, H., Manzoor, M. F., Trafiałek, J., et al. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70385 · Cited by 14
Immuno-onco-metabolism and Therapeutic Resistance
Mir, M. A., Aisha, S., Nisar, S., Qayoom, H., & Mehraj, U. (2022) · Springer eBooks · doi:10.1007/978-981-16-6226-3_3 · Cited by 11
Progress in the study of ferroptosis in cancer treatment: State-of-the-Art
Wang, D. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110348 · Cited by 11
Amino acids in hematologic malignancies: Current status and future perspective
Wang, M., Zhao, A., Li, M., & Niu, T. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1113228 · Cited by 11
System χc- overexpression prevents 2-deoxy-d-ribose-induced β-cell damage
Yoo, S., Bae, J. Y., Moon, J., & Koh, G. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.04.012 · Cited by 11
Quintanilla, M. E., Morales, P., Ezquer, F. E., Ezquer, M., Herrera‐Marschitz, M., & Israel, Y. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.617418 · Cited by 11
Chen, M., Hsu, L.-L., Wang, S., Pan, Y.-L., Lo, J., Yeh, T.-S., Tseng, L., & Lee, H. (2021) · Biomedicines · doi:10.3390/biomedicines9091101 · Cited by 12
Radioprotective effect of sulfasalazine on mouse bone marrow chromosomes
Mantena, S. K., Unnikrishnan, M. K., & Devi, P. U. (2008) · Mutagenesis · doi:10.1093/mutage/gen005 · Cited by 11
Natural Agents Modulating Ferroptosis in Cancer: Molecular Pathways and Therapeutic Perspectives
Amin, M. A., Zehravi, M., Sweilam, S. H., Jahnavi, P., Gupta, J. K., Rajashakar, V., Vodeti, R., Billah, A. A. M., Dharmamoorthy, G., Arjun, U. V. N. V., et al. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70834 · Cited by 11
Zhang, Z., Xie, B., Lu, X., Xiong, L., Li, X., Zhang, Y., Li, C., & Wang, C. (2023) · Nanoscale · doi:10.1039/d3nr04305c · Cited by 10
Implication of system xc− in neuroinflammation during the onset and maintenance of neuropathic pain
Beckers, P., do Nascimento, I. B., Charlier, M., Desmet, N., Massie, A., & Hermans, E. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03112-9 · Cited by 13
Kim, Y.-J., Lim, B., Kim, S. Y., Shin, Y.-Z., Yu, N., Shin, E.-K., Lee, J.-E., Jeon, Y. H., Kim, D., Lee, J., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116758 · Cited by 10
Pharmacologically Targeting Ferroptosis and Cuproptosis in Neuroblastoma
Liu, Y., Fleishman, J. S., Wang, H., & Huo, L. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04501-0 · Cited by 12
Ferroptosis Induction Enhances Photodynamic Therapy Efficacy for OLK
Yang, D., Yang, D., Song, Y. W., Liu, J., Wang, Y., Feng, X., Zeng, X., Chen, Q., Li, J., & Dan, H. (2024) · Journal of Dental Research · doi:10.1177/00220345241280257 · Cited by 10
Structure‐Activity‐Relationship‐Aided Design and Synthesis of xCT Antiporter Inhibitors
Cirillo, D., Sarowar, S., Enger, P. Ø., & Bjørsvik, H. (2021) · ChemMedChem · doi:10.1002/cmdc.202100204 · Cited by 10
Emerging roles of system antiporter and its inhibition in CNS disorders
Patel, D., Kharkar, P. S., & Nandave, M. (2015) · Molecular Membrane Biology · doi:10.3109/09687688.2015.1096972 · Cited by 10
Ferroptosis as a New Type of Cell Death and its Role in Cancer Treatment
Skoupilová, H., Michalová, E., & Hrstka, R. (2018) · Klinicka onkologie · doi:10.14735/amko20182s21 · Cited by 11
Effect of M2-like macrophages of the injured-kidney cortex on kidney cancer progression
Ishii, T., Mimura, I., Nagaoka, K., Naito, A., Sugasawa, T., Kuroda, R., Yamada, D., Kanki, Y., Kume, H., Ushiku, T., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01255-3 · Cited by 10
FAdV-4-induced ferroptosis affects fat metabolism in LMH cells
Dong, W., Du, K., Ding, Y., Liu, Y., Peng, L., Wu, C., Sun, Y., Li, Z., & Niu, Y. (2024) · Veterinary Microbiology · doi:10.1016/j.vetmic.2024.110068 · Cited by 9
Targeting Ferroptosis: Small-molecule Inducers as Novel Anticancer Agents
Jin, S., Wang, H., Zhang, Z., & Yan, M. (2024) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206342278241008081126 · Cited by 9
Innovative Therapeutic Strategies Targeting the Network Architecture of Glioblastoma
Beichert, J., Hoffmann, D. C., Winkler, F., & Ratliff, M. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-0018 · Cited by 11
Decoding the spatiotemporal characteristics of ferroptosis: reshaping tumour therapeutic strategies
Song, L., Shu, Y., Zhou, T., Wang, Y., Zhang, H., Liao, Y., Zhu, C., Zhang, W., & Zou, Z. (2026) · Experimental Hematology and Oncology · doi:10.1186/s40164-026-00773-5 · Cited by 9
Valvo, V., Parietti, E., Deans, K., Ahn, S. W., Park, N. R., Ferland, B., Thompson, D., Dominas, C. A., Bhagavatula, S. K., Davidson, S. M., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1032360 · Cited by 9
Dobis, D. R., Sawyer, R. T., Gillespie, M. M., Newman, L. S., Maier, L. A., & Day, B. J. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0150oc · Cited by 9
El-Dershaby, N. H., El-Hawash, S. A., Kassab, S. E., Daabees, H. G., Moneim, A. E. A., Wahab, I. A. A., Abd-Alhaseeb, M. M., & El-Miligy, M. M. M. (2022) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2022.2086868 · Cited by 9
Gu, L., Hu, X., Xue, Z., Yang, J., LiShu, W., Ren, Y., Hertz, L., & Peng, L. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.10.010 · Cited by 9
Linher‐Melville, K., Sharma, M., Nakhla, P., Kum, E., Ungard, R. G., Park, J. E., Rosa, D. A., Gunning, P. T., & Singh, G. (2019) · Molecular Pain · doi:10.1177/1744806918823477 · Cited by 9
Effect of sulfasalazine on ferroptosis during intestinal injury in rats after liver transplantation
Wu, W., Bao, X., Bu, W., Wang, Y., Tan, Y., wei, J., & wang, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-58057-z · Cited by 10
Xiao, W., & Xu, C. (2024) · Oncology Letters · doi:10.3892/ol.2024.14654 · Cited by 8
Ferroptosis in tumor associated immune cells: A double-edged sword against tumors
Hu, J., Cui, L., Hou, B., Ding, X., Liu, H., Sun, W., Mi, Y., Chen, Y., & Zou, Z. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104818 · Cited by 8
Ferroptosis as an approach to leverage cancer metabolism
Jin, J., Hu, J., Li, M., Gu, W., Jiang, X., & Stockwell, B. R. (2026) · Trends in Cell Biology · doi:10.1016/j.tcb.2026.03.008 · Cited by 8
Feng, Y., Li, X., Yang, B., Li, M., Du, Y., Wang, J., Liu, S., Gong, L., Li, L., & Gao, L. (2024) · Oncology Reports · doi:10.3892/or.2024.8738 · Cited by 9
Application of Nanomaterial-Mediated Ferroptosis Regulation in Kidney Disease
Zhu, J., Zhang, Z., Chu, Y., Xie, Z., Zeng, D., Jin, L., & Li, L. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s496644 · Cited by 8
Ferroptosis in Cancer Immunotherapy—Implications for Hepatocellular Carcinoma
Kusnick, J., Bruneau, A., Tacke, F., & Hammerich, L. (2022) · Immuno · doi:10.3390/immuno2010014 · Cited by 9
Ferroptosis: A potential opportunity for intervention of pre-metastatic niche
Zhuo, S., Yang, L., Chen, S., Tang, C., Li, W., Gao, Z., Feng, J., & Yang, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.980620 · Cited by 8
Mao, X., Liu, K., Shen, S.-Q., Meng, L., & Chen, S. (2023) · PubMed Central · Cited by 8
Bridges, R. J., & Patel, S. A. (2008) · Topics in medicinal chemistry · doi:10.1007/7355_2008_026 · Cited by 8
Safari, M. H., Rahimzadeh, P., Alaei, E., Alimohammadi, M., Esfandiari, N., Daneshi, S., Malgard, N., Farahani, N., Taheriazam, A., & Hashemi, M. (2025) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2025.102013 · Cited by 8
Tüfekci, K. K., & Tatar, M. (2023) · Journal of Cellular Neuroscience and Oxidative Stress · doi:10.37212/jcnos.1358141 · Cited by 7
Ge, T., Wang, Y., Han, Y., Bao, X., & Chunfeng, L. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01611-3 · Cited by 7
Choi, J., Park, M., Shin, S., Byeon, J., Lee, B. I., Park, Y., & Shin, Y. G. (2021) · Molecules · doi:10.3390/molecules26041179 · Cited by 7
Hsieh, C.-H., Huang, Y., & Tsai, T. (2022) · Dermatology and Therapy · doi:10.1007/s13555-022-00713-1 · Cited by 7
Peripheralized sepiapterin reductase inhibition as a safe analgesic therapy
Cronin, S. J. F., Andrews, N. A., & Latrémolière, A. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1173599 · Cited by 7
Ferroptosis and its modulators: A raising target for cancer and Alzheimer’s disease
Singh, G., Kesharwani, P., Singh, G. K., Kumar, S., Putta, A., & Modi, G. P. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117564 · Cited by 7
Hodgkin s disease with nephrotic syndrome as a complication of ulcerative colitis: case report.
Bašić‐Jukić, N., Radman, I., Rončević, T., & Jakić‐Razumović, J. (2002) · PubMed · Cited by 7
Ferroptosis and its relationship with cancer
Su, C., Xue, Y., Fan, S., Sun, X., Si, Q., Gu, Z., Wang, J., & Deng, R. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1423869 · Cited by 6
LRRC58 defines an E3 ubiquitin ligase complex sensitive to cysteine abundance
Ramage, D. E., Wieske, L. H. E., Crowe, C., Christensen, J. B., von Wilmowski, T. A., Bannister, Z., Grant, D. W., Nakasone, M. A., Haubrich, K., Dorward, M., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.06.014 · Cited by 7
Ferroptosis in hematological malignancies: molecular mechanisms and therapeutic potential
Liu, J., Liu, R., Miao, J., & He, A. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01142-w · Cited by 7
Day, Z. I., Mayfosh, A. J., Baxter, A. A., Williams, S. A., Hildebrand, J. M., Rau, T. F., Poon, I. K. H., & Hulett, M. D. (2024) · Biomolecules · doi:10.3390/biom14050555 · Cited by 6
Myeloid Derived Suppressor Cells: Subsets, Expansion, and Role in Cancer Progression
Abastado, J., & Zhi, L. (2012) · InTech eBooks · doi:10.5772/36409 · Cited by 6
Cysteine Metabolism in Cancer Progression and Therapy Resistance
Nin, D. S., Idres, S. B., & Deng, L. (2021) · Springer eBooks · doi:10.1007/978-981-16-0522-2_7 · Cited by 6
Small Molecule Regulators of Ferroptosis
Debieu, S., Solier, S., Colombeau, L., Versini, A., Sindikubwabo, F., Forrester, A. R., Müller, S., Cañeque, T., & Rodriguez, R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-62026-4_6 · Cited by 6
Sarowar, S., Cirillo, D., Játiva, P., Nilsen, M. H., Otragane, S.-M. A., Heggdal, J., Selheim, F., Ceña, V., Bjørsvik, H., & Enger, P. Ø. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.786739 · Cited by 6
Effect of early endometriosis on ovarian reserve and reproductive outcome
Kitaya, K. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/423 · Cited by 6
IDENTIFYING CANCER SPECIFIC METABOLIC SIGNATURES USING CONSTRAINT-BASED MODELS
Schultz, A., MEHTA, S., HU, C. W., Hoff, F. W., Horton, T. M., Kornblau, S. M., & Qutub, A. A. (2016) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789813207813_0045 · Cited by 6
Wang, S., Liu, Y., Wu, Z., Jin, Y., Zhang, T., Yang, Z., & Liu, C. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114559 · Cited by 5
Li, L., Zhang, J., Zhang, X., Wang, P., Ma, M., & Yin, B. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1580828 · Cited by 7
Overview and SWOT analysis of nano-ferroptosis therapy for cancers
Qian, C., Zhu, J., Jiang, J., & Huang, Z. (2025) · Nanoscale Horizons · doi:10.1039/d5nh00170f · Cited by 5
Seol, M. Y., Choi, S. H., & Yoon, H. I. (2025) · Journal of Neuro-Oncology · doi:10.1007/s11060-025-05128-4 · Cited by 5
Sharma, A., Srivastava, Y., Prasad, S., Ghosh, S., Kumar, R. S., Bharti, A. C., Singh, R. P., & Nasare, V. D. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149257 · Cited by 7
Ferroptosis at the intersection of radiotherapy and immunotherapy
Wei, G.-X., Zhao, Y., Tang, R., Shi, H., & Li, Z. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10306-x · Cited by 7
Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy
Xu, X., Wang, X., Jiang, W., Kamaruddin, W. H. A., Fang, C., & Zhang, P. (2026) · BMEMat · doi:10.1002/bmm2.70080 · Cited by 5
CRL2FEM1B uses heme to recruit BACH1 for degradation and regulate ferroptosis in lung cancer
Ahmed, B., Salaün, D., Jordan, J. B., Daulat, A. M., Pastorello, C., Brito, T., Yang, Y., Josselin, E., Byrne, D., Betzi, S., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.04.008 · Cited by 6
Deciphering Ferroptosis: From Molecular Pathways to Machine Learning-Guided Therapeutic Innovation
Mete, M., Ojha, A., Dhar, P., & Das, D. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01139-0 · Cited by 6
Tong, Y., Bai, S., Ou, L., Zhou, Q., Liu, S., Yin, L., Tang, K., Long, L., & Yin, Q. (2025) · Discover Oncology · doi:10.1007/s12672-025-02344-2 · Cited by 5
Shayanmanesh, M., Ahmadi, S. E., & Amini, A. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70790 · Cited by 4
Ferroptosis Resistance in Cancer: An Emerging Crisis of New Hope
Xu, D., Yonghui, L., Li, Y., Li, S., Wang, Z., & Wang, J. (2021) · BIO Integration · doi:10.15212/bioi-2020-0039 · Cited by 5
Biological protein mediated ferroptotic tumor nanotherapeutics
Tao, J., Li, C., Zheng, Y., Wang, F., Zhang, M., Wu, X., Chen, Y., Zeng, Q., Chen, F., & Fei, W. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01289d · Cited by 5
Tan, Y., Dong, X., Zhuang, D., Cao, B., Jiang, H., He, Q., & Zhao, M. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04694-3 · Cited by 5
Starving cancer cells to enhances DNA damage and immunotherapy response
Shahi, A., & Kidane, D. (2024) · Oncotarget · doi:10.18632/oncotarget.28595 · Cited by 5
Beckers, P., Charlier, M., Azria-Richter, L., Braconnier, P., Desmet, N., Massie, A., & Hermans, E. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110340 · Cited by 5
Metadata
- Authors
- Gout, P., Buckley, A., Simms, C., & Bruchovsky, N.
- Affiliations
- BC Cancer Agency (CA)
- University of Cincinnati Medical Center (US)
- Venue
- Leukemia
- Published
- 2001-10-01
- Volume
- 15
- Issue
- 10
- Pages
- 1633-1640
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2137749199
- Cited by
- 640
- References
- 41
- Citations by year
- 2026: 32 · 2025: 47 · 2024: 62 · 2023: 63 · 2022: 74 · 2021: 93 · 2020: 46 · 2019: 41 · 2018: 23 · 2017: 28 · 2016: 23 · 2015: 22 · 2014: 14 · 2013: 10 · 2012: 18
- FWCI
- 0.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Leukemia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ohio Cancer Research Associates
- National Institutes of Health (5r01dk053452-05)
- BC Cancer Agency
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 53452)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Sulfur Compounds in Biology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- sulfasalazine, cystine uptake, lymphoma, cysteine deficiency, non-Hodgkin lymphoma, sulfapyridine, 5-aminosalicylic acid, tumor growth inhibition, drug repurposing
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Antineoplastic Agents, Carrier Proteins, Cell Division, Drug Evaluation, Preclinical, Humans, Injections, Intraperitoneal, Lymphoma, Neoplasm Transplantation, Rats, Inbred Strains, Sulfasalazine, Tumor Cells, Cultured, Inhibitory Concentration 50, Amino Acid Transport System y+, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review